Navigation Links
Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop

the results indicated by these forward-looking statements, including: adverse results in its drug discovery and clinical development programs; failure to obtain patent protection for its discoveries; commercial limitations imposed by patents owned or controlled by third parties; the Company's dependence upon strategic alliance partners to develop and commercialize products and services based on its work; difficulties or delays in obtaining regulatory approvals to market products and services resulting from its development efforts; product withdrawals; competitive factors; difficulties or delays in manufacturing the Company's products; government and third-party reimbursement rates; the commercial success of VELCADE and INTEGRILIN(R) (eptifibatide) Injection; achieving revenue consistent with internal forecasts; and the requirement for substantial funding to conduct research and development and to expand commercialization activities. For a further list and description of the risks and uncertainties the Company faces, see the reports it has filed with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Editors' Note: This press release is also available under the Media section of the Company's website at: www.millennium.com. All session times listed are Eastern European Daylight Time.

CONTACT: Jennifer Snyder (media), +1-617-444-1439, or Kyle Kuvalanka(investors), +1-857-498-0818

Web site: http://www.millennium.com/

Company News On-Call: http://www.prnewswire.com/comp/114562.html /

Ticker Symbol: (NASDAQ-NMS:MLNM)

Terms and conditions of use apply
Copyright ©
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
3. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
4. Study Shows Velcade Plus Doxil Improves Survival in Previously Treated Patients With Multiple Myeloma
5. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
6. Millennium Discovers Biomarkers Potentially Predictive of Response to Velcade (Bortezomib) for Injection
7. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
10. Aquavan (Fospropofol Disodium) Injection Data Presented at Digestive Disease Week 2007
11. Hana Biosciences Announces Data to be Presented On Talvesta (Talotrexin) for Injection at The American Association for Cancer Research Annual Meeting
Post Your Comments:
(Date:8/31/2015)...  On August 5, 2015, the U.S. District Court ... denied motions to dismiss securities class action claims against ... of its directors. The class actions allege that the ... to artificially inflate Galena,s stock price, and during an ... inflated, sold massive amounts of their personally-held shares. ...
(Date:8/31/2015)... , Aug. 31, 2015 Regen BioPharma, ... development of a novel means of delivering its ... RGBP-248, to liver tumors utilizing a clinically approved ... overcomes previous hurdles with gene silencing therapeutics in ... delivered throughout the whole body.  By utilizing a ...
(Date:8/31/2015)... DIEGO , Aug. 31, 2015  Qualcomm ... its subsidiary, Qualcomm Life, Inc., is ... develop chronic care management solutions powered by Qualcomm ... Coordination Platform to enable continuous care, informed interventions ... were announced at Qualcomm Life,s annual Connect ...
Breaking Medicine Technology:Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5
... April 18, 2011 Altitude Organic Corporation (Pinksheets: ... announced today that it has launched its third-party ... headquarters.  Visit the DoctorMMJ.com website ( www.DoctorMMJ.com ) ... and entirely legal medical marijuana evaluation in Arizona. ...
... 2011 Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ... Administration (FDA) has accepted for review the Company,s Biologics ... of the neovascular form of age-related macular degeneration (wet ... priority review of its BLA.  A Priority Review designation ...
Cached Medicine Technology:Altitude Organic Corporation Opens DoctorMMJ.com Physician Referral Service in Scottsdale, Arizona 2Altitude Organic Corporation Opens DoctorMMJ.com Physician Referral Service in Scottsdale, Arizona 3FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration 2FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration 3
(Date:9/1/2015)... (PRWEB) , ... September 01, ... ... announce PRO Archiver for Alfresco, a next-generation customer communications archiving solution integrated ... with market-leading technology from Crawford and helps organizations save millions of dollars ...
(Date:9/1/2015)... ... September 01, 2015 , ... Award-winning adult film director and ... experiences of female beauty, women’s emotions, fertility, female violence and sexual assault. She ... their relationships with other men, documenting how the power balance between men and ...
(Date:9/1/2015)... York (PRWEB) , ... September 01, 2015 , ... Anthony ... of the Super Lawyers 2015 for his third consecutive year in a row. ... and accomplishments of helping people. , Born in Niagara Falls, New York, Tantillo is ...
(Date:9/1/2015)... ... 01, 2015 , ... A new episode of “Voices In America”, hosted by ... the topic of arthritis. There are over 100 different types of arthritis. One of ... statistics in an effort to shed light on this important topic. , Anyone who ...
(Date:9/1/2015)... ... September 01, 2015 , ... September is Baby Safety Month, ... safety labels and stickers to keep little ones' safety top of mind at all ... has a particular focus. According to the JPMA's Baby Safety Zone website, this year's ...
Breaking Medicine News(10 mins):Health News:Introducing Next-Generation Archiving Solution PRO Archiver for Alfresco® 2Health News:Introducing Next-Generation Archiving Solution PRO Archiver for Alfresco® 3Health News:Female Porn Director Explains Male Insecurities about Women in a New Book 2Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 2Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 3
... safely undergo essential dental treatment and receive topical and ... a study published in the June issue of ... Although obstetricians generally consider dental care safe for pregnant ... address this issue, researchers compared safety outcomes from the ...
... government,authorities reel from a record breaking year of food ... brings to light the science --,and the politics -- ... food and nuclear industries., Written plainly and passionately, ... timely and fact-filled. The book details the rise,of irradiation ...
... BeaconEquity.com announces the,availability of TraderNotes on stocks that are ... the daily trading notes for free by visiting:, http://www.BeaconEquity.com/m ... Sheets: LLSR),Elbit Imaging Ltd. (Nasdaq: EMITF ), Biolase ... (OTC Bulletin Board: OISI), Alcon Inc.,(NYSE: ACL ), ...
... up for America,s small,businesses., WASHINGTON, June 10 ... Democratic National Committee:, (Logo: http://www.newscom.com/cgi-bin/prnh/20080519/DNCLOGO ... up for America,s small businesses and,that "[e]ntrepreneurs are ... But in reality as president Senator McCain,s health ...
... IL June 10, 2008 Various intervention strategies have ... a factor that might affect exposure to interventionsis gender. ... Social Psychology reviewed the behavior of participants exposed ... and women were likely to avoid gender-mismatched brochures. Women, ...
... (NYSE:,HRC) invites you to listen to a presentation by ... Hill-Rom. He will be speaking,at the Jefferies Healthcare Conference ... p.m. EDT., You are invited to listen to ... or access it directly at, http://www.wsw.com/webcast/jeff26/hb . ...
Cached Medicine News:Health News:Essential dental treatment safe for pregnant women, says ADA journal study 2Health News:New Book Reveals Decades-Long Food Safety PR Scam 2Health News:BeaconEquity.com Issues TraderNotes on Medical Instruments and Supplies Stocks: LLSR, EMITF, BLTI, OISI, ACL, LMNX, MELA, PMII 2Health News:BeaconEquity.com Issues TraderNotes on Medical Instruments and Supplies Stocks: LLSR, EMITF, BLTI, OISI, ACL, LMNX, MELA, PMII 3Health News:Democratic National Committee McCain Myth Buster: John McCain and America's Small Businesses 2Health News:Democratic National Committee McCain Myth Buster: John McCain and America's Small Businesses 3Health News:Gender affects reaction to HIV-prevention materials 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: